A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
Clinical trial NCT03398655 · COMPLETED
Trial details
- NCT number
- NCT03398655
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2022-07-19
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.